• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21797 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of SARS-COV-2 virus in people with suspected COVID-19
2020     Health Technology Wales (HTW) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2015     NIHR Health Technology Assessment programme Rapid detection of health-care-associated bloodstream infection in critical care using multipathogen real-time polymerase chain reaction technology: a diagnostic accuracy study and systematic review
2023     NIHR Health and Social Care Delivery Program Rapid evaluation of service innovations in health and social care: key considerations
2023     NIHR Health Services and Delivery Research programme Rapid evaluation of the Special Measures for Quality and challenged provider regimes: a mixed-methods study
2013     NIHR Health Technology Assessment programme Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis
2020     Health Information and Quality Authority (HIQA) Rapid health technology assessment of alternative diagnostic testing approaches for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2023     Health Information and Quality Authority (HIQA) Rapid health technology assessment of continuous glucose monitoring in adults with type 1 diabetes mellitus
2023     Health Information and Quality Authority (HIQA) Rapid health technology assessment of the extension of the seasonal influenza vaccination programme to include those aged 50 to 64 years (general population)
2010     Adelaide Health Technology Assessment (AHTA) Rapid molecular assays for the diagnosis of sepsis and identification of sepsis causing pathogens
2006     Adelaide Health Technology Assessment (AHTA) Rapid point-of-care for the detection of Chlamydia in individuals at risk of trachoma
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response testing for the detection of clostridium difficile: a review of the diagnostic accuracy
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Clinical treatments for wrist ganglia. Report No. 63.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Diagnostic arthroscopy for conditions of the knee. Report No. 64.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Non-therapeutic male circumcision. Report No. 65.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Treatments for varicose veins. Report No. 66.
2008     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid Review - Upper airway surgery for the treatment of adult obstructive sleep apnoea. Report No. 67.
2021     Health Information and Quality Authority (HIQA) Rapid review of public health guidance for residential care facilities in the context of COVID-19
2021     Health Information and Quality Authority (HIQA) Rapid review of public health guidance on protective measures for vulnerable groups in the context of COVID-19
2008     Quality Improvement Scotland (NHS QIS ) Rapid review of the front-loaded model (FLM) and proposed application within the Scottish Ambulance Service (SAS)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rapid Rhythm ECG for atrial fibrillation
2016     Adelaide Health Technology Assessment (AHTA) Rapid sepsis detection
2008     NIHR Health Technology Assessment programme Rapid systematic review of the impact of participation in research
2008     Adelaide Health Technology Assessment (AHTA) Rapid test for Helicobacter pylori diagnosis of patients presenting with symptoms of dyspepsia
2009     Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009     NIHR Health Technology Assessment programme Rapid testing for group B streptococcus during labour: a test accuracy study with evaluation of acceptability and cost-effectiveness
2023     Agency for Care Effectiveness (ACE) Rapid to aid the diagnosis of patients suspected of stroke
2007     Adelaide Health Technology Assessment (AHTA) Rapid transcranial magnetic stimulation for stroke rehabilitation
2009     Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2007     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Rapid versus full systematic reviews: an inventory of current methods and practice in Health Technology Assessment. Report no 60
2014     NIHR Horizon Scanning Centre (NIHR HSC) RAPIDEC® CARBA NP test for confirmation or detection of Carbapenemase producing bacteria
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rarunavir/cobicistat (Rezolsta®)
2014     Medical Services Advisory Committee (MSAC) RAS (Kirsten RAS and Neuroblastoma RAS) mutation testing for eligibility for panitumumab treatment in previously untreated metastatic colorectal cancer patients.
2004     University HealthSystem Consortium (UHC) Rasagiline
2006     HAYES, Inc. Rasagiline for treatment of Parkinson's disease
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Rasburicase and hyperuricemia in cancer patients
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Rasburicase for adults with acute tumor lysis syndrome: a review of clinical and cost effectiveness and safety
2005     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Rate control versus serial electric cardioversion forchronic atrial fibrillation - primary research
2023     NIHR Health Technology Assessment programme Rates of medical or surgical treatment for women with heavy menstrual bleeding: the ECLIPSE trial 10-year observational follow-up study
2003     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational antibiotic utilisation in selected paediatric conditions
2003     Malaysian Health Technology Assessment Unit (MHTAU) Rational antibiotic utilisation in selected paediatric conditions
2005     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Rational use of analgesics in paediatrics
2006     Malaysian Health Technology Assessment Unit (MHTAU) Rational use of analgesics in paediatrics
1999     Unidad De Tecnologias De Salud (ETESA) Rational use of colloid solutions. Part I
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Rational vaccination policies - decision support. Review of international literature for "rational" vaccination policies
2021     Scottish Medicines Consortium (SMC) Ravulizumab for the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (PNH): in patients with haemolysis with clinical symptom(s) indicative of high disease activity; in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months
2022     NIHR Health Technology Assessment programme RCT of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to femoro-popliteal disease: BASIL-3 (Balloon vs Stenting in Severe Ischaemia of the Leg)
2008     University of York RCTs for policy interventions? A review of reviews and meta-regression - systematic review
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme: from assessment to expert appraisal
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Re-orientation of the Austrian parent-child preventive care programme. Part XI: Further development of the mother-child-pass: Screening recommendations of the expert working group for pregnancy, puerperium and early childhood (0-6 years)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
1996     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Re-use of medical devices
2017     NIHR Health Services and Delivery Research programme REACH: a mixed-methods study to investigate the measurement, prediction and improvement of retention and engagement in outpatient HIV care
2016     NIHR Horizon Scanning Centre (NIHR HSC) ReActiv8® implantable device for treating chronic low back pain
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Real-time (synchronous) telehealth in primary care: systematic review of systematic reviews
2014     Andalusian Health Technology Assessment Area (AETSA) Real-time 3D Transesophageal Echocardiography (RT-3D-TEE) versus 2D.
2009     Medical Services Advisory Committee (MSAC) Real-time measurement of cardiac output and other cardiac flow parameters (without concurrent cardiac imaging) using continuous wave Doppler techniques
2017     NIHR Health Technology Assessment programme Real-time modelling of a pandemic influenza outbreak
2021     Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2011     NIHR Horizon Scanning Centre (NIHR HSC) RealTime mS9 Colorectal Cancer (CRC) assay for the early detection of colorectal cancer
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Rebetron - hepatitis C
1994     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Receptor-imaging somatotropine inhibitor factor analogue in endocrine oncology - primary research
2009     HAYES, Inc. Reclast (Novartis Pharmaceuticals Corp.) for bone loss prevention during breast cancer chemotherapy
2015     University of York Recognising and managing frailty in primary care
2006     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated factor VII for prevention of bleeding unrelated to hemophilia: clinical and economic systematic review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant activated Factor VII in treatment of hemorrhage unrelated to hemophilia: a systematic review and economic evaluation
2002     University HealthSystem Consortium (UHC) Recombinant antihemophilic factor VIII
2022     Agency for Care Effectiveness (ACE) Recombinant blood products for prophylaxis and management of haemophilia A and B
2010     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant coagulation factor VIIa (rFVIIa) for treatment of bleeding and transient normalization of inr in patients on warfarin anticoagulation
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for life-threatening surgical and traumatic bleeding in non-haemophiliacs - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) for prevention and treatment of bleeding in patients with underlying disease - horizon scanning review
2004     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa (NovoSeven) in intracerebral haemorrhage (ICH) - horizon scanning review
2009     Penn Medicine Center for Evidence-based Practice (CEP) Recombinant factor VIIa for cardiovascular surgery
2002     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant factor VIIa in haemostatis - horizon scanning review
2002     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2012     HAYES, Inc. Recombinant growth hormone treatment for AIDS/HIV-associated wasting and lipodystrophy
2003     HAYES, Inc. Recombinant growth hormone treatment for burns, surgery, and critical illness
2003     HAYES, Inc. Recombinant growth hormone treatment for obesity
2003     HAYES, Inc. Recombinant growth hormone treatment in children
2002     HAYES, Inc. Recombinant growth hormone treatment in growth hormone-deficient adults
2014     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human alpha-mannosidase (Lamazym) for alpha mannosidosis
2014     HAYES, Inc. Recombinant human bone morphogenetic protein (rhBMP) for use in spinal fusion
2004     HAYES, Inc. Recombinant human bone morphogenetic protein for use in bone repair
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in spinal fusion
2006     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2011     HAYES, Inc. Recombinant human bone morphogenetic protein for use in tibia repair
2001     Blue Cross Blue Shield Association (BCBS) Recombinant human growth hormone (GH) therapy in adults with age-related GH deficiency
1998     ECRI Recombinant human growth hormone for AIDS wasting
2010     NIHR Health Technology Assessment programme Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
2000     ECRI Recombinant human growth hormone for the treatment of idiopathic short stature
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Recombinant human growth hormone for treatment of Turner Syndrome: systematic review and economic evaluation
2013     HAYES, Inc. Recombinant human growth hormone treatment in children under 2 years of age
2012     NIHR Horizon Scanning Centre (NIHR HSC) Recombinant human N-acetylgalactosamine-6-sulfatase (rhGALNS) for mucopolysaccharidosis type IVA – first line
2005     ECRI Recombinant human osteogenic protein-1 [rhOP-1] for healing nonunion fractures of the tibia